Assessment of cortical and striatal involvement in 523 Huntington disease brains

Neurology

Volumn 79, Issue 16, 2012, Pages 1708-1715

  Hadzi, Tiffany C ^a   Hendricks, Audrey E ^b   Latourelle, Jeanne C ^a   Lunetta, Kathryn L ^b   Cupples, L Adrienne ^b   Gillis, Tammy ^c   Mysore, Jayalakshmi Srinidhi ^c   Gusella, James F ^c   MacDonald, Marcy E ^c   Myers, Richard H ^a   Vonsattel, Jean Paul ^d  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d New York Presbyterian Morgan Stanley Children's Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN CORTEX; BRAIN REGION; BRAIN TISSUE; BRAIN WEIGHT; CAG REPEAT; CAUDATE NUCLEUS; CELL LOSS; CLUSTER ANALYSIS; COMORBIDITY; CONTROLLED STUDY; CORPUS STRIATUM; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; FEMALE; GLIOSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; HUNTINGTON CHOREA; MAJOR CLINICAL STUDY; MALE; MICROSCOPY; NEUROPATHOLOGY; ONSET AGE; PARKINSON DISEASE; PRIORITY JOURNAL; PUTAMEN; RATING SCALE;

EID: 84871210721     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e31826e9a5d     Document Type: Article

References (20)

1. Group THsDCR. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes: The Huntington's Disease Collaborative Research Group. Cell 1993;72:971-983.
2. Wexler NS, Lorimer J, Porter J, et al. Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington's disease age of onset. Proc Natl Acad Sci USA 2004;101:3498-3503.
3. Vonsattel JP, Myers RH, Stevens TJ, Ferrante RJ, Bird ED, Richardson EP Jr. Neuropathological classification of Huntington's disease. J Neuropathol Exp Neurol 1985;44: 559-577.
4. Kassubek J, Juengling FD, Kioschies T, et al. Topography of cerebral atrophy in early Huntington's disease: a voxel based morphometric MRI study. J Neurol Neurosurg Psychiatry 2004;75:213-220.
5. Rosas HD, Salat DH, Lee SY, et al. Cerebral cortex and the clinical expression of Huntington's disease: complexity and heterogeneity. Brain 2008;131:1057-1068.
6. Aylward EH, Nopoulos PC, Ross CA, et al. Longitudinal change in regional brain volumes in prodromal Huntington disease. J Neurol Neurosurg Psychiatry 2011;82:405-410.
7. Cudkowicz M, Kowall NW. Degeneration of pyramidal projection neurons in Huntington's disease cortex. Ann Neurol 1990;27:200-204.
8. Sotrel A, Williams RS, Kaufmann WE, Myers RH. Evidence for neuronal degeneration and dendritic plasticity in cortical pyramidal neurons of Huntington's disease: a quantitative Golgi study. Neurology 1993;43:2088-2096.
9. Sotrel A, Paskevich PA, Kiely DK, Bird ED, Williams RS, Myers RH. Morphometric analysis of the prefrontal cortex in Huntington's disease. Neurology 1991;41:1117-1123.
10. de la Monte SM, Vonsattel JP, Richardson EP Jr. Morphometric demonstration of atrophic changes in the cerebral cortex, white matter, and neostriatum in Huntington's disease. J Neuropathol Exp Neurol 1988; 47:516-525.
11. Rosas HD, Tuch DS, Hevelone ND, et al. Diffusion tensor imaging in presymptomatic and early Huntington's disease: Selective white matter pathology and its relationship to clinical measures. Mov Disord 2006;21:1317-1325.
12. Bird ED. The brain in Huntington's chorea. Psychol Med 1978;8:357-360.
13. Mann DM, Oliver R, Snowden JS. The topographic distribution of brain atrophy in Huntington's disease and progressive supranuclear palsy. Acta Neuropathol 1993;85: 553-559.
14. Myers RH, Vonsattel JP, Stevens TJ, et al. Clinical and neuropathologic assessment of severity in Huntington's disease. Neurology 1988;38:341-347.
15. Guidetti P, Luthi-Carter RE, Augood SJ, Schwarcz R. Neostriatal and cortical quinolinate levels are increased in early grade Huntington's disease. Neurobiol Dis 2004;17: 455-461.
16. Richards G, Messer J, Waldvogel HJ, et al. Up-regulation of the isoenzymes MAO-A and MAO-B in the human basal ganglia and pons in Huntington's disease revealed by quantitative enzyme radioautography. Brain Res 2011; 1370:204-214.
17. Hodges A, Strand AD, Aragaki AK, et al. Regional and cellular gene expression changes in human Huntington's disease brain. Hum Mol Genet 2006;15:965-977.
18. Ryu H, Lee J, Hagerty SW, et al. ESET/SETDB1 gene expression and histone H3 (K9) trimethylation in Huntington's disease. Proc Natl Acad Sci USA 2006;103:19176-19181.
19. Li JL, Hayden MR, Almqvist EW, et al. A genome scan for modifiers of age at onset in Huntington disease: The HD MAPS study. Am J Hum Genet 2003;73:682-687.
20. Thu DC, Oorschot DE, Tippett LJ, et al. Cell loss in the motor and cingulate cortex correlates with symptomatology in Huntington's disease. Brain 2011;133:1094-1110.